Symptomatic Val122del mutated hereditary transthyretin amyloidosis: Need for early diagnosis and prioritization for heart and liver transplantation

2021 ◽  
Author(s):  
Adriano-Valerio Schettini ◽  
Laura Llado ◽  
Julie K Heimbach ◽  
Jose Gonzalez Costello ◽  
Marie Tranäng ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Early Diagnosis ◽  
Transthyretin Amyloidosis ◽  
Hereditary Transthyretin Amyloidosis

Effects of liver transplantation and tafamidis in hereditary transthyretin amyloidosis caused by transthyretin Leu55Pro mutation: a case report

Amyloid ◽  
2015 ◽  
Vol 22 (3) ◽  
pp. 203-204 ◽  
Author(s):  
Tomoya Kon ◽  
Yohei Misumi ◽  
Haruo Nishijima ◽  
Masaki Honda ◽  
Chieko Suzuki ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Case Report ◽  
Transthyretin Amyloidosis ◽  
Hereditary Transthyretin Amyloidosis

scholarly journals Liver transplantation for hereditary transthyretin amyloidosis

2000 ◽  
Vol 6 (3) ◽  
pp. 263-276 ◽  
Author(s):  
Ole B. Suhr ◽  
Gustav Herlenius ◽  
Styrbjörn Friman ◽  
Bo-Göran Ericzon
Keyword(s):  
Liver Transplantation ◽  
Transthyretin Amyloidosis ◽  
Hereditary Transthyretin Amyloidosis

scholarly journals New Medications in the Treatment of Hereditary Transthyretin Amyloidosis

2018 ◽  
Vol 53 (4) ◽  
pp. 236-238 ◽  
Author(s):  
Scot Walker
Keyword(s):  
Liver Transplantation ◽  
Transthyretin Amyloidosis ◽  
Abnormal Protein ◽  
Slow Progression ◽  
Approved Drugs ◽  
Hereditary Transthyretin Amyloidosis

Hereditary transthyretin amyloidosis is an inherited disorder that results in the gradual progressive deposit of abnormal protein called amyloid in the body’s organs and tissues. There are currently no approved drugs to treat transthyretin amyloidosis, and patients may require liver transplantation for survival. There are a few drugs in development to treat hereditary transthyretin amyloidosis either by stabilizing the abnormal protein or by decreasing production of transthyretin. Both methods are being developed to slow progression of the disease.

Clinicopathological and biochemical findings of late-onset hereditary transthyretin amyloidosis 16 years after liver transplantation: an autopsy case study

Amyloid ◽  
2017 ◽  
Vol 24 (sup1) ◽  
pp. 122-122
Author(s):  
Mayumi Mizukami ◽  
Mitsuharu Ueda ◽  
Masayoshi Tasaki ◽  
Yohei Misumi ◽  
Teruaki Masuda ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Late Onset ◽  
Autopsy Case ◽  
Transthyretin Amyloidosis ◽  
Hereditary Transthyretin Amyloidosis

scholarly journals Cardiac Dysautonomia Predicts Long-Term Survival in Hereditary Transthyretin Amyloidosis After Liver Transplantation

2016 ◽  
Vol 9 (12) ◽  
pp. 1432-1441 ◽  
Author(s):  
Vincent Algalarrondo ◽  
Teresa Antonini ◽  
Marie Théaudin ◽  
Denis Chemla ◽  
Anouar Benmalek ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Transthyretin Amyloidosis ◽  
Term Survival ◽  
Long Term Survival ◽  
Hereditary Transthyretin Amyloidosis

Amyloid Fibril Composition as a Predictor of Development of Cardiomyopathy After Liver Transplantation for Hereditary Transthyretin Amyloidosis

2012 ◽  
Vol 93 (10) ◽  
pp. 1017-1023 ◽  
Author(s):  
Sandra Gustafsson ◽  
Elisabet Ihse ◽  
Michael Y. Henein ◽  
Per Westermark ◽  
Per Lindqvist ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Amyloid Fibril ◽  
Transthyretin Amyloidosis ◽  
Hereditary Transthyretin Amyloidosis

Clinicopathological and biochemical findings of thyroid amyloid in hereditary transthyretin amyloidosis with and without liver transplantation

Amyloid ◽  
2017 ◽  
Vol 24 (1) ◽  
pp. 24-29 ◽  
Author(s):  
Guannan Huang ◽  
Mitsuharu Ueda ◽  
Masayoshi Tasaki ◽  
Taro Yamashita ◽  
Yohei Misumi ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Transthyretin Amyloidosis ◽  
Hereditary Transthyretin Amyloidosis
Sign in / Sign up

Export Citation Format

Share Document